dr. J.F.M. (Job) van Boven

A/Prof. dr. Job van Boven is a real-world drug outcomes expert specialised in lung diseases. He is the founding director of the Medication Adherence Expertise Center Of the northern Netherlands (MAECON) and Chair of the European Commission funded European Network to Advance Best Practices & Technology on Medication Adherence (ENABLE) COST Action, comprising 40 countries. He leads the research group on Cost-effective Drug Use (in Dutch: Doelmatig, Duurzaam & Digitaal ondersteund Geneesmiddelgebruik) at the Department of Clinical Pharmacy & Pharmacology of the University Medical Center Groningen and is Principal Investigator at the Groningen Research Institute for Asthma and COPD (GRIAC) and Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET) group of the UMCG.
He obtained his PharmD and PhD at the University of Groningen (The Netherlands), where his thesis focused on the cost-effectiveness of adherence enhancing interventions in patients with Chronic Obstructive Pulmonary Disease (COPD). After his PhD research, he completed fellowships at the University of Colorado (USA), Monash University (Australia) and the Hospital Universitario Son Espases (Spain).
He is (co)author of >200 scientific publications (H-index: 44), supervisor of 15 PhD students (7 completed) and received several research prices & grants (totalling>€6 million). He is Chair of the European Respiratory Society CRC on digital respiratory health "CONNECT", Boardmember of the Lung Alliance Netherlands (LAN), research faculty at the IPCRG, former Boardmember of the Dutch young Medicines Evaluation Board (Jong CBG), Chair of the Dutch respiratory pharmacists group (KNMP SIG Long), ZonMW-GGG committee member, and has an extensive international network (e.g. ERS, IPCRG, EAACI, ISPE, REG, ESPACOMP, ISPOR).
Having interest and wide experience in both medication adherence and health economic methods, his mission is to find novel, cost-effective ways to achieve better, personalized and sustainable use of our respiratory medications in order to maximize both patients’ and societal benefits.
Through multidisciplinary research, education and care support, he aims to provide means to accelerate implementation of drug-device technologies (digital inhalers, electronic pill bottles & blisters and smart spacers) and practical adherence monitoring & management tools (e.g. the TAI Toolkit) in daily clinical practice, to ultimately optimize patient, economic and societal outcomes.

Specialties:
- Methods & application: real-world drug outcomes, medication adherence, compliance, persistence, e-health, smart inhalers, bottles and spacers, digital adherence technology, (pharmaco) epidemiology, sustainable drug use, health technology assessment, cost-effectiveness.
- Disease focus areas: Asthma / COPD / TB / CF / Lung transplantation / Lung cancer  

Founding director Medication Adherence Expertise Center of the northern Netherlands (MAECON)
Chair European Network to Advance Best practices & technoLogy on medication adherencE (ENABLE) COST Action
Chair of the Dutch respiratory pharmacists group
Former Committee member ZonMW Good Medication Use (GGG)
Former Boardmember Dutch young Medicines Evaluation Board (CBG-MEB)
Editorial board member of the journals "npj Primary Care Respiratory Medicine", "Frontiers in Medical Technology", "Clinical eHealth", "Tuberculosis & Respiratory Diseases" and "Pragmatic & Observational Research"
International Primary Care Respiratory Group (IPCRG) Research Leadership team (Member)
Respiratory Effectiveness Group (REG) Adherence Working Groep (Member)
Ad-hoc consultant to various companies (ALK, AstraZeneca, Chiesi, GSK, Novartis, TEVA, Vertex)
Technical Board member, Makerere University Lung Institute, Uganda
Co-Chair European Respiratory Society (ERS) Clinical Research Collaboration (CRC) "CONNECT" on digital respiratory health
Board member Lung Alliance Netherlands (LAN)
Scientific Advisory Committee Dutch Lung Foundation (Longfonds)